Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy of CompuFlo® Technology in Thoracic Epidural Space Identification

NCT: NCT05798754 · NOT_YET_RECRUITING

NCT IDNCT05798754
StatusNOT_YET_RECRUITING
Start Date2027-04
Completion2028-03
SponsorGeneral and Maternity Hospital of Athens Elena Venizelou (OTHER)
First posted
Last updated

Brief Summary

The aim of this non inferiority trial is to assess the efficacy of CompuFlo® technology to identify the thoracic epidural space in relation to the gold standard loss of resistance technique.

Frequently Asked Questions

What is Efficacy of CompuFlo® Technology in Thoracic Epidural Space Identification?

Efficacy of CompuFlo® Technology in Thoracic Epidural Space Identification is a clinical trial registered under NCT05798754. Current status: NOT_YET_RECRUITING.

What is the status of NCT05798754?

The current status of NCT05798754 (Efficacy of CompuFlo® Technology in Thoracic Epidural Space Identification) is: NOT_YET_RECRUITING.

When did Efficacy of CompuFlo® Technology in Thoracic Epidural Space Identification start?

Efficacy of CompuFlo® Technology in Thoracic Epidural Space Identification started on 2027-04.

Related Devices

K172410Portex NRFit Epidural Needles, Portex NRFit Spinal Needles, Portex NRFit Loss of Resistance (L.O.R.) Syringes., Portex EpiFuse Catheter Connector, Portex Regional Anaesthesia Portfolio FiltersSmiths Medical Asd, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑